Mehdi Hemmati
Papers
1
Total Citations
8
H-Index
1
About
Mehdi Hemmati is a researcher whose work sits at the critical intersection of surgical oncology, radiation therapy, and patient quality of life, with a primary focus on oropharyngeal squamous cell cancer (OPSCC). His key research area involves developing optimized, data-driven decision-support frameworks to guide the complex choice between transoral robotic surgery (TORS) and (chemo)radiation therapy. His major contribution, detailed in his 2022 highly-cited paper (8 citations), is a novel model that directly integrates posttreatment swallowing toxicity—a paramount concern for survivors—into the treatment selection process. By explicitly accounting for the inherent uncertainties of TORS, such as the risk of postoperative residual positive margins and extranodal extension, Hemmati’s work moves beyond traditional survival metrics to prioritize functional outcomes. This pioneering approach provides clinicians with a powerful, evidence-based tool to personalize care, helping to balance oncologic efficacy with the preservation of essential functions like swallowing. His research is notable for its direct clinical applicability, offering a tangible path toward reducing long-term morbidity in head and neck cancer survivors and establishing a new benchmark for patient-centered decision-making in this challenging field.
Research Focus
Key Achievements
Top Papers
- 1